Electroporation enhances protective immune response of a DNA vaccine against Japanese encephalitis in mice and pigs
- 1 November 2016
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 34 (47), 5751-5757
- https://doi.org/10.1016/j.vaccine.2016.10.001
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81271839, 81301435, 81471957, 81372935, 81401676)
This publication has 18 references indexed in Scilit:
- Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trialThe Lancet, 2015
- A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of Electroporated HIV DNA with or without Interleukin 12 in Prime-Boost Combinations with an Ad35 HIV Vaccine in Healthy HIV-Seronegative African AdultsPLOS ONE, 2015
- Regional Variation in Pig Farmer Awareness and Actions Regarding Japanese Encephalitis in Nepal: Implications for Public Health EducationPLOS ONE, 2014
- Therapeutic DNA Vaccination Using In Vivo Electroporation Followed by Standard of Care Therapy in Patients With Genotype 1 Chronic Hepatitis CMolecular Therapy, 2013
- DNA vaccines: roles against diseasesGERMS, 2013
- DNA vaccines: an historical perspective and view to the futureImmunological Reviews, 2010
- Japanese encephalitis: update on vaccines and vaccine recommendationsCurrent Opinion in Infectious Diseases, 2010
- Disability from Japanese encephalitis in Cambodia and Viet NamJournal of Tropical Pediatrics, 2010
- Ecology and Geographical Expansion of Japanese Encephalitis VirusAnnual Review of Entomology, 2009
- DNA vaccines: ready for prime time?Nature Reviews Genetics, 2008